Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Appears Close To Beginning Trump Transition Process

Executive Summary

With HHS and CMS leaders nominated, President-elect Trump’s team now may move to US FDA evaluation, commissioner candidates.

Advertisement

Related Content

Woodcock Tries To Calm US FDA Staff Fears About Trump
Will US FDA Wind Up With More Political Positions Under Trump?
Gottlieb Joins HHS Transition Team; Will Next Stop Be FDA?
Gottlieb Joins HHS Transition Team; Will Next Stop Be FDA?
Trump’s HHS, CMS Leadership Choices Underscore Focus On ACA Reform
One Step Forward, Two Steps Back: Regulatory Reform May Be Tougher On CMS Than On FDA
Trump’s FDA Reform Agenda: Patient-Focused Approvals
Califf Maintains Desire To Stay At FDA, But Would Either Presidential Candidate Keep Him?
FDA's Breakthrough Workload Will Be Eased By Hiring Reviewers With PDUFA VI Funds

Topics

Advertisement
UsernamePublicRestriction

Register

PS119594

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel